Engineered probiotic restores GLP-1 signaling to ameliorate fiber-deficiency exacerbated colitis
Science Advances · 07.11.2025 · 11 (45)
DOI: 10.1126/sciadv.adx6869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.11.2025. Verfasst von Leonie Brockmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Probiotics, Colitis, Dietary Fiber. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Western diets reduced in fiber promote dysbiosis and exacerbate colitis, with short-chain fatty acids (SCFAs) from fiber fermentation known to regulate glucagon-like peptide 1 (GLP-1) secretion. Whether GLP-1 dysregulation directly links diet-induced dysbiosis to colitis severity, and if this pathway can be therapeutically targeted independently of dietary fiber, remains unclear. Here, we show that dextran sulfate sodium (DSS)–induced colitis severity correlates with compensatory GLP-1 increases, while receptor blockade worsens damage, confirming GLP-1’s protective role during colitis. Fiber deficiency impaired L cell function and GLP-1 release, increasing colitis susceptibility. GLP-1 receptor agonist reversed these effects, restoring barrier integrity and accelerating recovery. We engineered a probiotic, releasing a microbial peptide, that locally elevates GLP-1, which normalized gut parameters in fiber-deprived mice and alleviated colitis via GLP-1–dependent mechanisms, including improved metabolism, antimicrobial defenses , and barrier restoration. Our findings mechanistically connect fiber deficiency to colitis through GLP-1 and demonstrate that probiotic-mediated GLP-1 modulation can bypass dietary fiber requirements to maintain gut homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
- Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q), Keio University, Tokyo 108-8345, Japan.
- Innovative Genomics Institute at UC Berkley, Berkley, CA 94720, USA.
- Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University, New York, NY 10032, USA.
- Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.
- Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Leonie Brockmann, Carlotta Ronda, Yiming Qu, Daniel W Shneider, Chrystal F Mavros, Ivaylo I Ivanov, Govind Bhagat, Harris H Wang
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- Wellcome Trust
- NIBIB NIH HHS
Zitieren
APA
Brockmann, L., Ronda, C., Schwanz, L. T., Qu, Y., Shneider, D. W., Mavros, C. F., Ivanov, I. I., Bhagat, G., & Wang, H. H. (2025). Engineered probiotic restores GLP-1 signaling to ameliorate fiber-deficiency exacerbated colitis. Science Advances, 11(45). https://doi.org/10.1126/sciadv.adx6869
Vancouver
Brockmann L, Ronda C, Schwanz LT, Qu Y, Shneider DW, Mavros CF, et al. Engineered probiotic restores GLP-1 signaling to ameliorate fiber-deficiency exacerbated colitis. Science Advances. 2025;11(45). doi:10.1126/sciadv.adx6869
BibTeX
@article{Brockmann2025,
author = {Brockmann, Leonie and Ronda, Carlotta and Schwanz, Logan T and Qu, Yiming and Shneider, Daniel W and Mavros, Chrystal F and Ivanov, Ivaylo I and Bhagat, Govind and Wang, Harris H},
title = {Engineered probiotic restores GLP-1 signaling to ameliorate fiber-deficiency exacerbated colitis},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {45},
doi = {10.1126/sciadv.adx6869}
}
EUVIMED